Clinical trial
Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With…
NCT00466089 · Hospital of Navarra, Other · Unknown status
Key facts
| NCT number | NCT00466089 |
|---|---|
| Title | Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer |
| Official title | Phase II Randomized Trial of 3D Radiotherapy Versus the Combination of 3D Radiotherapy and Erlotinib (Tarceva®) in Patients With Localized-Unresectable Non-Small Cell Lung Cancer Non Susceptible for Chemotherapy Treatment. |
| Lead sponsor | Hospital of Navarra, Other |
| Collaborators | Dr. Enrique Martínez López |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Erlotinib (Tarceva®) |
| Enrollment | 90 |
| Start date | Mar 1, 2006 |
| First posted | Apr 27, 2007 |
| Last update posted | Jan 10, 2008 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: